Semaglutide decreases the chance for cardiovascular disease. Which has not but been demonstrated for tirzepatide. The drug also cuts down complications in individuals with kidney disease.In August, Novo Nordisk, the maker of Ozempic and Wegovy, turned the very first to display in a significant scientific demo which the drugs provide overall health